Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A humanized antibody against CD40 (SGN-40) is well tolerated and active in non-Hodgkin's lymphoma (NHL): Results of a phase I study. Forero-Torres, A., Furman, R. R., Rosenblatt, J. D., Younes, A., Harrop, K., Drachman, J. G., Advani, R. AMER SOC CLINICAL ONCOLOGY. 2006: 430S
View details for Web of Science ID 000239009403023